Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Enumeral Biomedical Logo
Enumeral Biomedical (closed)
Enumeral Biomedical uses a nanotechnology-enabled process for therapeutic discovery, immune profiling and personalized medicine.
Closed Founded
obfuscation
DelistedPost-IPO Debt New York, New York, United States11-50 enumeral.com
Biotechnology
Nanotechnology
Precision Medicine
Therapeutics

Enumeral Biomedical is permanently closed. If you feel this is an error, let us know.

Overview

Enumeral Biomedical
Total Funding
obfuscation
Heat Score
4

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score
pts
in past quarter
Heat Score 4
-18 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Enumeral Biomedical

Enumeral Biomedical uses a nanotechnology-enabled process for therapeutic discovery, immune profiling and personalized medicine.
Closed Founded
obfuscation
DelistedPost-IPO Debt New York, New York, United States11-50 enumeral.com
Biotechnology
Nanotechnology
Precision Medicine
Therapeutics

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Enumeral Biomedical Holdings, Inc.
Operating Status Closed
Stock Symbol  OTCQB:ENUM
Company Type For Profit
Founders  Arthur H. Tinkelenberg, John J. Rydzewski
About the Company
Enumeral Biomedical uses its microengraving (nanotechnology-enabled) process to address opportunities in immunology including therapeutic discovery, immune profiling and personalized medicine.
Phone Number 2127523633
Contact Email info@enumeral.com
Predictions & Insights

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Enumeral Biomedical Logo
Post-IPO Debt - Enumeral Biomedical
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Enumeral Biomedical Logo
Post-IPO Debt - Enumeral Biomedical
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Enumeral Biomedical Logo
Post-IPO Debt - Enumeral Biomedical
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Enumeral Biomedical Logo
Post-IPO Debt - Enumeral Biomedical
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Enumeral Biomedical Logo
Post-IPO Debt - Enumeral Biomedical
—
obfuscation
— Post-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Enumeral Biomedical Logo
Post-IPO Debt - Enumeral Biomedical
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Enumeral Biomedical Logo
Post-IPO Debt - Enumeral Biomedical
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Enumeral Biomedical Logo
Post-IPO Debt - Enumeral Biomedical
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Enumeral Biomedical Logo
Post-IPO Debt - Enumeral Biomedical
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Enumeral Biomedical Logo
Post-IPO Debt - Enumeral Biomedical
—
obfuscation
— Post-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
180 Degree Capital Logo
180 Degree Capital
—
Post-IPO Equity - Enumeral Biomedical Logo
Post-IPO Equity - Enumeral Biomedical
—
180 Degree Capital Logo
180 Degree Capital
—
Post-IPO Equity - Enumeral Biomedical Logo
Post-IPO Equity - Enumeral Biomedical
—
180 Degree Capital Logo
180 Degree Capital
—
Post-IPO Equity - Enumeral Biomedical Logo
Post-IPO Equity - Enumeral Biomedical
—
180 Degree Capital Logo
180 Degree Capital
—
Post-IPO Equity - Enumeral Biomedical Logo
Post-IPO Equity - Enumeral Biomedical
—
180 Degree Capital Logo
180 Degree Capital
—
Post-IPO Equity - Enumeral Biomedical Logo
Post-IPO Equity - Enumeral Biomedical
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Board Members and Advisors 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jan 3, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 14, 2013
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Actively Used Products

9Enumeral Biomedical uses 9 technology products and services including HTML5, GoDaddy Premium DNS, and  Google Maps API, according to G2 Stack.

Active Website Tech Count

2Enumeral Biomedical is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is Enumeral Biomedical's headquarters? Enumeral Biomedical is located in New York, New York, United States.Who invested in Enumeral Biomedical? Enumeral Biomedical has 3 investors including 180 Degree Capital and  Montrose Capital Partners.When was the last funding round for Enumeral Biomedical? Enumeral Biomedical closed its last funding round on
obfuscation
from a Post-IPO Debt round.How much funding has Enumeral Biomedical raised to date? Enumeral Biomedical has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(d29fb2e 1)
|